期刊文献+

鸟苷产生菌解淀粉芽孢杆菌的选育 被引量:2

Breeding of Strain Bacillus amyloliquefaciens for Guanosine-Producing
下载PDF
导出
摘要 出发菌GR001通过形态观察、生理生化实验、16S rDNA同源性序列分析及部分特异性基因序列分析鉴定为解淀粉芽孢杆菌.以GR001为出发菌,通过化学诱变选育出一株遗传标记为腺嘌呤营养缺陷、6–巯基嘌呤抗性以及蛋氨酸亚砜抗性(Ade-+MSOr+6-MPr)的突变株GR600.以GR600为受体菌,采用原生质体转化法获得转化子GR607(Ade-+MSOr+6-MPr+kmr),鸟苷产量高达20.82,g/L. According to the characteristics of morphology, physiology and biochemistry experiment and the comparison of 16S rDNA and pur-operon sequence, original strain GR001 was identified as Bacillus amyloliquefaciens. A mutant GR600 (Ade^- + MSO^r+6-MP^r) was obtained from GR001 by DES treatment. GR600 as a recipient, with the method Of protoplast transformation, a transformant GR607 (Ade ^-+ MSO^r+6-Mp^r + km^r) was obtained, guanosine production can reach 20.82 g/L.
出处 《天津科技大学学报》 CAS 2010年第2期1-4,共4页 Journal of Tianjin University of Science & Technology
基金 国家科技重大专项课题(2008ZX09401-05)
关键词 鸟苷 解淀粉芽孢杆菌 诱变 原生质体 guanosine Bacillus amyloliquefaciens mutation protoplast
  • 相关文献

参考文献13

  • 1应国清,石陆娥,唐振兴,单剑峰.核苷酸的生产及其在医药食品中的应用[J].食品研究与开发,2004,25(4):120-123. 被引量:7
  • 2王浩,武钦佩.核苷类抗病毒化合物的研究进展[J].生命科学仪器,2006,4(1):11-14. 被引量:3
  • 3张文婷,倪孟祥,张绍谭.核苷类抗病毒药物进展[J].抗感染药学,2005,2(2):55-59. 被引量:6
  • 4Momose H ,Nishikawa H, Katsuya N. Regulation of purine nucleotide synthesis in Bacillus subtilis. I. Enzyme repression by purine derivatives [J]. Gen App Microbiol, 1964 (10) :343-349.
  • 5Matsui H,Sato K,Enei H,et al. Mutation of an inosineproducing strain of Bacillus subtilis to DL-methionine sulfoxide resistance for guanosine production[J]. Appl Environ Microbiol, 1977,34 (4) :337-341.
  • 6张蓓,张克旭,王健,陈宁.基于途径分析的鸟苷发酵条件优化[J].云南大学学报(自然科学版),2004,26(S2):74-78. 被引量:2
  • 7Chen X H,Koumoutsi A,Scholz R,et al. Comparative analysis of the complete genome sequence of the plant growth-promoting bacterium Bacillus amyloliquefaciens FZB42[J]. Nat Biotechnol,2007,25 (9) : 1007-1014.
  • 8陈宁,张克旭,王东洋,李建河.L-谷氨酸生产菌的选育及其发酵条件的研究[J].发酵科技通讯,2002,31(1):11-13. 被引量:5
  • 9奥斯伯FM,金斯顿RE,赛德曼JG,等.精编分子生物学实验指南[M].4版.马学军,舒跃龙,译.北京:科学出版社.2005.
  • 10BuchananRE,Gibbens NE.伯杰氏细菌鉴定手册[M].中国科学院微生物研究所《伯杰细菌鉴定手册》翻译组,译.8版.北京:科学出版社,1984:729-751.

二级参考文献58

  • 1张蓓.鸟苷产生的原生质体诱变育种及其发酵条件的研究[J].天津微生物,1994(1):32-35. 被引量:3
  • 2关维先,关月秋.嘌呤类抗病毒物的进展[J].中国医药情报,1995,1(3):182-185. 被引量:9
  • 3郑明祺.胃癌的化学治疗进展[J].中国药理学通报,1996,21(4):296-298. 被引量:2
  • 4[3]De C1ercq E Antiviral drugs:current state of the art[J].Journal of clinical virology.2001,22(1):73~89.
  • 5[6]Quan DJ, Peters MG. Antiviral therapy: nucleotide and nucleoside analogs[J]. Clin Liver Dis, 2004, 8(2):371~385.
  • 6[7]Schinazi RF, Mellors J, Bazmi H, et al. DPC 817: a cytidine nucleoside analog with activity against zidovudine and lamivudineresistant viral variants[J]. Antimicrob Agents Chemother, 2002,46(5):1394~1401.
  • 7[8]Otto MJ. New nucleoside reverse transcriptase inhibitors for the treatment of HIV infections[J]. Curr Opin Phannacol, 2004, 4(5):431~436.
  • 8[9]Akitsu T, Takeuchi Y, Einaga Y. Racemic 3,5-dichloro-2-[[(1- phenylethyl) imino]methyl]phenol[J]. Acta Crystallogr C, 2004, 60(11):801-802.
  • 9[10]Otto MJ. New nucleoside reverse transcriptase inhibitors for the treatment of HIV infections[J]. Curr Opin Pharmacol, 2004, 4(5):431~436.
  • 10[11]Borroto-Esoda K, Myrick F, Feng J, et al. In vitro combination of amdoxovir and the inosine monophosphate dehydrogenase inhibitors mycophenolic acid and ribavirin demonstrates potent activity against wild-type and drug-resistant variants of human immunodeficiency virus type l[J]. Antimicrob AgentsChemother,2004, 48(11):4387~4394.

共引文献24

同被引文献24

引证文献2

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部